On the other hand, although GPX1 has not been reported to be involved in ferroptosis, is thought to contribute to worsening prognosis, tumor growth, and treatment resistance in several cancers, including breast and bladder cancer, via its antioxidative activity50–52. This evidence concerns the gene GPX1 and neoplasm.